A Critical Moment in the COVID-19 Fight



By:

Americans now have widespread access to two vaccines that offer protection against COVID-19, with a third — the single-dose Johnson & Johnson vaccine approved by the FDA on February 27 — expected to reach providers in the coming weeks.
READ MORE

Meeting the Challenge of Vaccine Administration



By:

As soon as the scale and seriousness of the COVID-19 pandemic became clear in early 2020, talk began to focus on the challenges of developing vaccines. The past year has seen an unprecedented effort to develop and deploy safe and effective vaccines to control a virus that has now claimed 2.5 million lives worldwide — and more than 500,000 in the U.S. alone.
READ MORE